Duquesne Family Office LLC is an institution, managing $3.2B across 56 long positions as of Q3 2025 with 31% Healthcare concentration, 56% concentrated in top 10 holdings, and 16% allocation to NTRA.
Largest long holdings in Duquesne Family Office LLC's portfolio (56.1% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Medical - Diagnostics & Research Healthcare | $517.4M | 16.22% | +$20.8M Bought | 2.34% 3.2M shares | |
Biotechnology Healthcare | $349.0M | 10.94% | +$24.5M Bought | 1.15% 2.4M shares | |
Aerospace & Defense Industrials | $160.0M | 5.01% | -$54.6M Sold | 1.06% 633.0K shares | |
Specialty Retail Consumer Cyclical | $149.2M | 4.68% | +$17.0M Bought | 0.25% 4.6M shares | |
Specialty Retail Consumer Cyclical | $136.3M | 4.27% | +$10.8M Bought | 0.12% 58.3K shares | |
Software - Application Technology | $121.5M | 3.81% | +$28.5M Bought | 0.84% 1.7M shares | |
ETF ETF | $101.5M | 3.18% | +$101.5M Bought | — 1.9M shares | |
Specialty Retail Consumer Cyclical | $96.0M | 3.01% | +$96.0M Bought | 0.00% 437.1K shares | |
Entertainment Communication Services | $82.4M | 2.58% | -$27.8M Sold | 0.56% 822.4K shares | |
Unknown Unknown | $77.0M | 2.41% | +$77.0M New | — 2.1M shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Duquesne Family Office LLC's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
New | |
New |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
Sold |
Portfolio insights and performance metrics for Duquesne Family Office LLC
We use cookies for analytics. See our Privacy and Cookie Policy.